Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Jun;81(12):3864-8.
doi: 10.1073/pnas.81.12.3864.

Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody

Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody

D L Faustman et al. Proc Natl Acad Sci U S A. 1984 Jun.

Abstract

Previously we have demonstrated that islets of Langerhans treated with donor-specific anti-Ia serum and complement survive when transplanted across the major histocompatibility complex of the mouse. In this study, using immunofluorescence, we demonstrate two morphologically distinct populations of Ia-positive cells scattered within the Ia-negative islet tissue. A large irregularly shaped Ia-positive subset of cells were identified as dendritic cells by using the 33D1 antibody specific for a mouse dendritic cell antigen. The other small, round Ia-positive subset was 33D1 negative. Islets pretreated with anti-dendritic cell antibody and complement prior to transplantation survived in their histoincompatible recipients for greater than 200 days. Rejection of stable islet allografts promptly occurred when transplant recipients were challenged with 1 X 10(5) donor dendritic cells 60 days after transplantation. These results demonstrate an important in vivo role for donor dendritic cells in the stimulation of allograft rejection.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Endocrinology. 1969 Aug;85(2):218-23 - PubMed
    1. Transplantation. 1983 Sep;36(3):346-8 - PubMed
    1. J Exp Med. 1974 Feb 1;139(2):380-97 - PubMed
    1. J Exp Med. 1974 Jun 1;139(6):1431-45 - PubMed
    1. J Immunol. 1974 Jul;113(1):181-8 - PubMed

Publication types

Substances